Molluscum contagiosum (MC), a viral skin infection caused by the poxvirus, often presents challenges in treatment due to limited therapeutic options. However, a potential breakthrough has emerged with ... Please provide your email address to receive an email when new articles are posted on .

Understanding the Context

MIAMI BEACH, Fla. — Two new treatment options for molluscum contagiosum could be available in the near future as ... Zelsuvmi is expected to be available in the second half of 2024. The Food and Drug Administration (FDA) has approved Zelsuvmi ™ (berdazimer topical gel) for the treatment of molluscum contagiosum in ...

Key Insights

Topical cantharidin (Ycanth) was approved as the first treatment specifically for molluscum contagiosum, the FDA announced. Molluscum contagiosum is a viral skin infection that affects as many as 6 ... Yahoo Finance: Verrica Pharmaceuticals Announces Launch of YCANTH® for the Treatment of Molluscum Contagiosum in Japan by Partner Torii Pharmaceutical Verrica Pharmaceuticals Announces Launch of YCANTH® for the Treatment of Molluscum Contagiosum in Japan by Partner Torii Pharmaceutical Everyday Health: What Is Molluscum Contagiosum? Symptoms, Causes, Diagnosis, Treatment, and Prevention The Food and Drug Administration (FDA) has accepted for filing the New Drug Application for cantharidin 0.7% topical solution (VP-102; Verrica Pharmaceuticals) for the treatment of molluscum ...